Key Insights

Highlights

Success Rate

96% trial completion (above average)

Published Results

86 trials with published results (12%)

Research Maturity

504 completed trials (69% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

2.6%

19 terminated out of 735 trials

Success Rate

96.4%

+9.8% vs benchmark

Late-Stage Pipeline

2%

13 trials in Phase 3/4

Results Transparency

17%

86 of 504 completed with results

Key Signals

86 with results96% success19 terminated

Data Visualizations

Phase Distribution

698Total
Not Applicable (149)
Early P 1 (11)
P 1 (513)
P 2 (12)
P 3 (5)
P 4 (8)

Trial Status

Completed504
Recruiting105
Active Not Recruiting35
Not Yet Recruiting31
Terminated19
Unknown15

Trial Success Rate

96.4%

Benchmark: 86.6%

Based on 504 completed trials

Clinical Trials (735)

Showing 20 of 20 trials
NCT07746908Phase 1CompletedPrimary

Bioequivalence Study of Valsatril Tablet Versus Entresto® Sacubitril/Valsartan 24/26 mg Tablet.

NCT07626515Phase 1RecruitingPrimary

A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Enicepatide in Generally Healthy Adult Chinese Participants

NCT07498270Not ApplicableRecruiting

Location- and Frequency-Dependent Effects of Thalamic Temporal Interference Stimulation During Sleep

NCT07219719Phase 1RecruitingPrimary

Temporal Interference for Thalamocortical Activity and Network Modulation

NCT07755332CompletedPrimary

Association Between Central Sensitization and the Root Mean Square of Successive Differences

NCT07511205Phase 1RecruitingPrimary

A Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD1043 in Healthy Adult Participants Living With Overweight and/or Obesity.

NCT07751250Phase 1Not Yet RecruitingPrimary

Comparative PK Assessment Study of Casdatifan in Moderate Hepatically Impaired Participants Versus Matched Participants With Normal Hepatic Function

NCT07746817Phase 1Not Yet Recruiting

A Study of BYN-001 in Healthy Adults and in Adults With Moderate to Severe Atopic Dermatitis

NCT06854042Phase 1Active Not Recruiting

A Study of Oral E1018 in Healthy Adult Participants

NCT07753252Phase 1Not Yet RecruitingPrimary

Phase 1 Study in Healthy Adults to See How Sevabertinib Changes Metformin Levels in the Body

NCT06627231Phase 1CompletedPrimary

Mass Balance Clinical Trial With TEV-56286

NCT07479576Phase 1CompletedPrimary

A Comparative Phase 1 Study to Evaluate the Pharmacokinetic and Safety of QL2106 vs Tremfye® in Healthy Subjects

NCT07746167RecruitingPrimary

Pupillary Dilation Reflex in Healthy Volunteers

NCT07745114Phase 1Active Not RecruitingPrimary

SAL0137 Phase I Study in in Healthy Participants With or Without Elevated Lp(a)

NCT07745907Phase 1RecruitingPrimary

A Phase 1 Trial of AMG 691 in Healthy Chinese and Japanese Volunteers

NCT07513571Phase 1CompletedPrimary

A Study to Assess the Effect of AZD0780 on the Pharmacokinetics of AZD4954 and Vice Versa in Healthy Adults

NCT07723833Phase 1RecruitingPrimary

A Study to Investigate the Relative Bioavailability and Safety of Different Oral Formulations of Elecoglipron in Healthy Participants

NCT01060371Recruiting

Natural History Study of and Genetic Modifiers in Spinocerebellar Ataxias

NCT07290283Phase 1RecruitingPrimary

A Study to Investigate Safety, Tolerability, and Pharmacokinetics of AZD3974 in Healthy Participants

NCT07738991Phase 1RecruitingPrimary

A Study to Investigate the Pharmacokinetics, Pharmacodynamics, and Safety of NKF-PEG, and US-Neulasta in Healthy Adult Male Volunteers

Scroll to load more

Research Network

Activity Timeline